Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis

Hepatitis C Virus Infection Increases Risk of Developing End-Stage Renal Disease Using Competing Risk Analysis

BACKGROUND Chronic kidney disease (CKD) and hepatitis C virus (HCV) infection are closely linked and both increase patient mortality. The association of HCV and risk of developing end-stage renal disease (ESRD) has not been analyzed with competing risk model. METHOD We enrolled a prospective cohort of 4,185 patients (mean age, 62 years; 41% female) registered in the CKD integrated care progra...

Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease.

BACKGROUND Infection with chronic hepatitis C virus (HCV) has been linked to glomerulonephritis. We undertook this study to determine whether having a positive HCV test result was associated with an increased risk for developing treated end-stage renal disease (ESRD). METHODS Using data from Medicare, the Department of Veterans Affairs, and the United States Renal Data System, we performed a ...

Competing Risk Analyses of Patients with End-Stage Renal Disease

INTRODUCTION Chronic kidney disease (CKD) is an important health problem that gradually leads to end-stage renal disease (ESRD). In ESRD patients, death due to other diseases or some events, such as renal transplantation (known as competing risks), would change the probability of observing the event of interest. The aim of this study was to estimate the survival of ESRD patients using competing...

Hepatitis B Infection in End-Stage Renal Disease Patients in Khuzestan Province, Iran

Systemic Diseases and the Kidney RISK FACTORS IN THE POPULATION WITH END-STAGE RENAL DISEASE AND HEPATITIS C VIRUS INFECTION

Reuse [71,72] FIGURE 7-7 Risk of HCV in the ESRD population. Numerous studies have demonstrated a strong association between the prevalence of hepatitis C virus (HCV) infection among patients receiving dialysis and both the number of transfusions received and duration of dialysis [53,61]. Although these two variables are related, the prevalence of anti-HCV in these patients has been shown to be...